Related Experiment Videos
Update on drugs in advanced ovarian cancer
1Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, Ohio.
Clinical Advances in Hematology & Oncology : H&O
|July 11, 2020
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Prognostic value of the nutritional risk index and prognostic nutritional index for immunotherapy outcomes in cervical Cancer.
Gynecologic oncology reports·2026
Assessment of probiotic and prebiotic use in gynecologic cancer patients: a systematic review.
American journal of obstetrics and gynecology·2025
Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2025
The microbiome and gynecologic cancer: cellular mechanisms and clinical applications.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2025
Assessment of socioeconomic and racial differences in patients undergoing concurrent gynecologic oncology and urogynecology surgeries: a National Inpatient Sample (NIS) database study.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2025
Artificial intelligence in prostate cancer diagnosis and management: state-of-the-art approaches and emerging innovations.
Clinical advances in hematology & oncology : H&O·2026
Clinical applications of PARP inhibitors in breast, ovarian, and prostate cancer: current insights and future directions.
Clinical advances in hematology & oncology : H&O·2026
Molecular residual disease (MRD) testing: advancing clinical decision-making in breast cancer.
Clinical advances in hematology & oncology : H&O·2026